Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas. uri icon

Overview

publication date

  • May 1, 2024

Identity

Scopus Document Identifier

  • 85189544103

Digital Object Identifier (DOI)

  • 10.1038/s41591-024-02957-0

PubMed ID

  • 38570701

Additional Document Info

volume

  • 30

issue

  • 5